Close
revogene card images

SARS-CoV-2 Testing

A real-time Reverse Transcription Polymerase Chain Reaction (rRT-PCR) qualitative test run on the Revogene® instrument for the detection of SARS-CoV-2 nucleic acid from nasopharyngeal, oropharyngeal, anterior nasal, and mid-turbinate nasal swab specimens.

Catalog Number: 410700

Why Revogene SARS-CoV-2

The Revogene® SARS-CoV-2 assay is a real-time RT-PCR test intended for the qualitative detection of RNA from SARS-CoV-2 in nasopharyngeal, oropharyngeal, anterior nasal, and mid-turbinate nasal swab specimens from individuals suspected of COVID-19 by their healthcare provider. Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. § 263a, that meet requirements to perform high or moderate complexity tests.

  • sample_result_icon

    Automated, streamlined workflow – sample to result in 2 easy steps

  • Group 12 Created with Sketch.

    Time-saving, walk-away efficiencies with little hands-on-time

  • Group 13 Created with Sketch.

    Advanced molecular diagnostic accuracy – 97.7% PPA , 97.7% NPA

  • expansion_icon

    Platform for growth – Single analyte and multiplex testing capability

Improve Efficiency, Deliver Standardization

  • Near patient testing with Revogene® provides a rapid turnaround time which optimizes patient management by providing an earlier diagnosis for improved patient outcomes
  • Revogene® can help infections from being transmitted to others through rapid execution of infection prevention strategies
  • Revogene® provides clinicians with actionable results for faster treatment decisions
revogene

“CDC recommends that anyone with any signs or symptoms of COVID-19 get tested, regardless of vaccination status or prior infection.”

Reference: https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/testing.html

Support & Documents

Downloadable PDFs

FAQs

CPT Code 87635 

Nasopharyngeal, anterior nasal, mid-turbinate nasal, or oropharyngeal swab specimens collected according to standard technique and placed in 3 mL of transport media according to manufacturer’s instructions.  

Swab specimens collected in VTM/UTM can be stored at 2-8 C for up to seven (7) days before being tested with the Revogene SARS-CoV-2 assay.  Specimens collected in CDC media, MicroTest M4RT® (Remel), or saline may be stored up to 72 hours at 2-8 C before use. 

The Revogene SARS-CoV-2 kit can be stored at 2-8 C.  The expiration date is indicated on the kit box label. For more information, please refer to the Revogene SARS-CoV-2 package insert. 

Get In Touch With A Specialist


Welcome to
logo blue

Please select your country to continue

Continue
CN